Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study.

Journal of the International AIDS Society
María Jose MíguezRobert M Malow

Abstract

In vitro studies suggest that reducing cholesterol inhibits HIV replication. However, this effect may not hold in vivo, where other factors, such as cholesterol's immunomodulatory properties, may interact. Fasting blood samples were obtained on 165 people living with HIV at baseline and after 24 weeks on highly active antiretroviral therapy (HAART). Participants were classified as hypocholesterolemic (HypoCHL; <150 mg/dl) or non-HypoCHL (>150 mg/dl) and were compared on viro-immune outcomes. At baseline, participants with HypoCHL (40%) exhibited lower CD4 (197 +/- 181 vs. 295 +/- 191 cells/mm3, p = 0.02) and CD8 (823 +/- 448 vs. 1194 +/- 598 cells/mm3, p = 0.001) counts and were more likely to have detectable viral loads (OR = 3.5, p = 0.01) than non-HypoCHL controls. After HAART, participants with HypoCHL were twice as likely to experience a virological failure >400 copies (95% CI 1-2.6, p = 0.05) and to exhibit <200 CD4 (95% CI 1.03-2.9, p = 0.04) compared with non-HypoCHL. Low thymic output was related to poorer CD4 cell response in HypoCHL subjects. Analyses suggest a dose-response relationship with every increase of 50 mg/dl in cholesterol related to a parallel rise of 50 CD4 cells. The study implicates, for the first time...Continue Reading

References

May 1, 1993·The American Journal of Medicine·Gail Shor-PosnerMarianna K Baum
Jun 1, 1994·European Journal of Clinical Investigation·J ConstansH Fleury
Aug 1, 1997·Clinical Immunology and Immunopathology·M F MuldoonS B Manuck
Jan 22, 1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·A J ClaxtonK R Feingold
Nov 24, 1998·Epidemiology and Infection·C IribarrenK R Feingold
Aug 4, 2001·AIDS Research and Human Retroviruses·Z LiaoJ E Hildreth
Oct 9, 2001·HIV Clinical Trials·UNKNOWN Panel on Clinical Practices for Treatment of HIV Infection
Jan 5, 2002·Atherosclerosis·Olga SteinYechezkiel Stein
Jun 12, 2003·JAMA : the Journal of the American Medical Association·Sharon A RiddlerLawrence A Kingsley
Sep 19, 2003·AIDS Research and Human Retroviruses·Zhaohao LiaoJames E K Hildreth
Aug 7, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Scott M GrundyUNKNOWN Coordinating Committee of the National Cholesterol Education Program
Oct 12, 2004·Biochemical and Biophysical Research Communications·Claire Hunter-LavinJohn H H Williams
Dec 24, 2004·Molecular Interventions·Dzung H Nguyen, Dennis D Taub
Mar 15, 2005·Journal of Cell Science·Lawrence Rajendran, Kai Simons
Sep 27, 2005·AIDS·Gemma MoncunillJosé A Esté
Oct 24, 2006·Journal of Leukocyte Biology·Michael Bukrinsky, Dmitri Sviridov
Nov 2, 2006·PLoS Biology·Zahedi MujawarDmitri Sviridov
Jun 21, 2007·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Benigno RodriguezIan Woolley
Nov 30, 2007·The Lancet Infectious Diseases·Jisun Oh, Robert A Hegele
May 12, 2009·The Journal of the Association of Nurses in AIDS Care : JANAC·Maria J Míguez-BurbanoRobert Malow
Jun 13, 2009·Journal of the American College of Cardiology·Diane E Bild, Michael S Lauer

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry

Software Mentioned

SPSS

Related Concepts